• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一场涉及NPM1白血病突变体、核磷蛋白和ARF的剂量依赖性拔河比赛。

A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.

作者信息

Bolli N, De Marco M F, Martelli M P, Bigerna B, Pucciarini A, Rossi R, Mannucci R, Manes N, Pettirossi V, Pileri S A, Nicoletti I, Falini B

机构信息

Section of Haematology and Immunology, Department of Clinical and Experimental Medicine, University of Perugia, IBiT Foundation, Fondazione IRCCS Biotecnologie nel Trapianto, Perugia, Italy.

出版信息

Leukemia. 2009 Mar;23(3):501-9. doi: 10.1038/leu.2008.326. Epub 2008 Nov 13.

DOI:10.1038/leu.2008.326
PMID:19005479
Abstract

In acute myeloid leukaemia (AML), nucleophosmin-1 (NPM1) mutations create a nuclear export signal (NES) motif and disrupt tryptophans at NPM1 C-terminus, leading to nucleophosmin accumulation in leukaemic cell cytoplasm. We investigated how nucleophosmin NES motifs (two physiological and one created by the mutation) regulate traffic and interaction of mutated NPM1, NPM1wt and p14(ARF). Nucleophosmin export into cytoplasm was maximum when the protein contained all three NES motifs, as naturally occurs in NPM1-mutated AML. The two physiological NES motifs mediated NPM1 homo/heterodimerization, influencing subcellular distribution of NPM1wt, mutated NPM1 and p14(ARF) in a 'dose-dependent tug of war' fashion. In transfected cells, excess doses of mutant NPM1 relocated completely NPM1wt (and p14(ARF)) from the nucleoli to the cytoplasm. This distribution pattern was also observed in a proportion of NPM1-mutated AML patients. In transfected cells, excess of NPM1wt (and p14(ARF)) relocated NPM1 mutant from the cytoplasm to the nucleoli. Notably, this distribution pattern was not observed in AML patients where the mutant was consistently cytoplasmic restricted. These findings reinforce the concept that NPM1 mutants are naturally selected for most efficient cytoplasmic export, pointing to this event as critical for leukaemogenesis. Moreover, they provide a rationale basis for designing small molecules acting at the interface between mutated NPM1 and other interacting proteins.

摘要

在急性髓系白血病(AML)中,核磷蛋白-1(NPM1)突变产生一个核输出信号(NES)基序,并破坏NPM1 C末端的色氨酸,导致核磷蛋白在白血病细胞质中积累。我们研究了核磷蛋白NES基序(两个生理性的和一个由突变产生的)如何调节突变型NPM1、野生型NPM1和p14(ARF)的转运和相互作用。当蛋白质包含所有三个NES基序时,核磷蛋白向细胞质的输出最大,这在NPM1突变的AML中自然发生。两个生理性NES基序介导NPM1同源/异源二聚化,以“剂量依赖性拔河”方式影响野生型NPM1、突变型NPM1和p14(ARF)的亚细胞分布。在转染细胞中,过量的突变型NPM1将野生型NPM1(和p14(ARF))从核仁完全重新定位到细胞质中。在一部分NPM1突变的AML患者中也观察到这种分布模式。在转染细胞中,过量的野生型NPM1(和p14(ARF))将NPM1突变体从细胞质重新定位到核仁。值得注意的是,在突变体始终局限于细胞质的AML患者中未观察到这种分布模式。这些发现强化了这样的概念,即NPM1突变体是为了最有效的细胞质输出而自然选择的,表明这一事件对白血病发生至关重要。此外,它们为设计作用于突变型NPM1与其他相互作用蛋白之间界面的小分子提供了理论基础。

相似文献

1
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.一场涉及NPM1白血病突变体、核磷蛋白和ARF的剂量依赖性拔河比赛。
Leukemia. 2009 Mar;23(3):501-9. doi: 10.1038/leu.2008.326. Epub 2008 Nov 13.
2
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants.天生用于输出:不同强度的羧基末端核输出信号确保核磷蛋白白血病突变体在细胞质中积累。
Cancer Res. 2007 Jul 1;67(13):6230-7. doi: 10.1158/0008-5472.CAN-07-0273.
3
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.NPM1突变的急性髓系白血病中核磷蛋白转运改变:分子基础及临床意义
Leukemia. 2009 Oct;23(10):1731-43. doi: 10.1038/leu.2009.124. Epub 2009 Jun 11.
4
A Curious Novel Combination of () Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of in Acute Myeloid Leukemia (AML).急性髓系白血病(AML)中导致异常细胞质移位的()基因突变的奇特组合。
Genes (Basel). 2021 Sep 16;12(9):1426. doi: 10.3390/genes12091426.
5
Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant.白血病相关的核仁磷酸蛋白(NPM)突变体导致Arf肿瘤抑制因子的去定位和不稳定。
Cancer Res. 2006 Mar 15;66(6):3044-50. doi: 10.1158/0008-5472.CAN-05-2378.
6
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.在NPMc+急性髓系白血病中,羧基末端核输出信号(NES)基序和突变的色氨酸对于核磷蛋白白血病突变体异常的核输出都至关重要。
Blood. 2006 Jun 1;107(11):4514-23. doi: 10.1182/blood-2005-11-4745. Epub 2006 Feb 2.
7
Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf.鉴定肿瘤抑制因子 p14arf 中核磷蛋白相互作用的新基序。
FEBS J. 2018 Mar;285(5):832-847. doi: 10.1111/febs.14373. Epub 2018 Jan 15.
8
Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.天然产物(+)-阿夫拉米维拉胺与核磷蛋白和输出蛋白-1的相互作用介导了核磷蛋白及其与急性髓性白血病相关突变体的细胞定位。
ACS Chem Biol. 2015 Mar 20;10(3):855-63. doi: 10.1021/cb500872g. Epub 2015 Jan 5.
9
Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal.NPM在髓系白血病中的细胞质定位由产生功能性核输出信号的功能获得性突变决定。
Oncogene. 2006 Jul 20;25(31):4376-80. doi: 10.1038/sj.onc.1209453. Epub 2006 Feb 27.
10
Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.伴有核磷蛋白(NPM1)突变的急性髓系白血病:分子、病理及临床特征
Cancer Treat Res. 2010;145:149-68. doi: 10.1007/978-0-387-69259-3_9.

引用本文的文献

1
Abnormal nucleoli architecture and aggregate formation in nucleophosmin mutated acute myeloid leukaemia.核仁素突变的急性髓系白血病中的异常核仁结构和聚集体形成
J Cell Sci. 2025 May 15;138(10). doi: 10.1242/jcs.263553. Epub 2025 May 21.
2
Tumor-Agnostic Therapy-The Final Step Forward in the Cure for Human Neoplasms?肿瘤不可知疗法——人类肿瘤治愈的最后一步?
Cells. 2024 Jun 20;13(12):1071. doi: 10.3390/cells13121071.
3
AML-Related NPM Mutations Drive p53 Delocalization into the Cytoplasm with Possible Impact on p53-Dependent Stress Response.
与急性髓系白血病相关的核仁磷酸蛋白突变促使p53从细胞核移位至细胞质,可能影响p53依赖的应激反应。
Cancers (Basel). 2021 Jun 29;13(13):3266. doi: 10.3390/cancers13133266.
4
An updated account on molecular heterogeneity of acute leukemia.急性白血病分子异质性的最新报道。
Am J Blood Res. 2021 Feb 15;11(1):22-43. eCollection 2021.
5
NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization.NSC348884 的细胞毒性不是通过抑制核仁磷酸蛋白寡聚化来介导的。
Sci Rep. 2021 Jan 13;11(1):1084. doi: 10.1038/s41598-020-80224-1.
6
miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia.miR-10a 作为急性髓系白血病中 MDM2 抑制的治疗靶点和预测生物标志物。
Leukemia. 2021 Jul;35(7):1933-1948. doi: 10.1038/s41375-020-01095-z. Epub 2020 Dec 1.
7
A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.急性髓系白血病中实施个性化医学的遗传改变和分子靶向治疗的全面综述。
J Mol Med (Berl). 2020 Aug;98(8):1069-1091. doi: 10.1007/s00109-020-01944-5. Epub 2020 Jul 3.
8
Nucleophosmin 1 Mutations in Acute Myeloid Leukemia.核仁磷酸蛋白 1 突变在急性髓系白血病中的作用。
Genes (Basel). 2020 Jun 12;11(6):649. doi: 10.3390/genes11060649.
9
Role of Nucleophosmin Gene Mutation in Leukemogenesis of Acute Myeloid Leukemia.核磷蛋白基因突变在急性髓系白血病白血病发生中的作用
J Hematol. 2018 Jan;7(1):7-13. doi: 10.14740/jh365w. Epub 2017 Jan 10.
10
New insights into the biology of acute myeloid leukemia with mutated NPM1.具有突变 NPM1 的急性髓细胞白血病的生物学新见解。
Int J Hematol. 2019 Aug;110(2):150-160. doi: 10.1007/s12185-018-02578-7. Epub 2019 Jan 10.